EPISODE · Aug 7, 2025 · 38 MIN
Eli Lilly’s Obesity Pill & Tim Cook at the White House 8/7/25
from Squawk Pod · host CNBC
President Trump has announced he will impose a 100% tariff on chips and semiconductors imports, although he’s suggested exemptions for companies manufacturing in the U.S. One company that may qualify for that exemption: Apple. During CEO Tim Cook’s meeting with the President on Wednesday, Cook committed an additional $100 billion to onshore manufacturing. Author Walter Isaacson discusses Cook’s commitment in the context of Steve Jobs’ original plans to manufacture Apple products in America. President Trump also has another tech CEO in his sights, calling for the resignation of Intel’s Lip-Bu Tan on social media. CNBC’s Angelica Peebles reveals the latest obesity pill trial results from Eli Lilly. Orfoglipron’s results were similar to Wegovy, and investors are disappointed by the data and the rate of discontinuation among trial participants. Plus, Lyft CEO David Risher explains his company’s earnings report, strong on paper but disappointing to some investors. Megan Cassella - 5:35Angelica Peebles - 13:03Walter Isaacson - 20:47David Risher - 35:21 In this episode:Megan Cassella, @mmcassellaAngelica Peebles, @angelicapeeblesJoe Kernen, @JoeSquawk Andrew Ross Sorkin, @andrewrsorkinMelissa Lee, @MelissaLeeCNBCKatie Kramer, @Kramer_Katie Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
What this episode covers
President Trump has announced he will impose a 100% tariff on chips and semiconductors imports, although he’s suggested exemptions for companies manufacturing in the U.S. One company that may qualify for that exemption: Apple. During CEO Tim Cook’s meeting with the President on Wednesday, Cook committed an additional $100 billion to onshore manufacturing. Author Walter Isaacson discusses Cook’s commitment in the context of Steve Jobs’ original plans to manufacture Apple products in America. President Trump also has another tech CEO in his sights, calling for the resignation of Intel’s Lip-Bu Tan on social media. CNBC’s Angelica Peebles reveals the latest obesity pill trial results from Eli Lilly. Orfoglipron’s results were similar to Wegovy, and investors are disappointed by the data and the rate of discontinuation among trial participants. Plus, Lyft CEO David Risher explains his company’s earnings report, strong on paper but disappointing to some investors. Megan Cassella - 5:35 Angelica Peebles - 13:03 Walter Isaacson - 20:47 David Risher - 35:21 In this episode: Megan Cassella, @mmcassella Angelica Peebles, @angelicapeebles Joe Kernen, @JoeSquawk Andrew Ross Sorkin, @andrewrsorkin Melissa Lee, @MelissaLeeCNBC Katie Kramer, @Kramer_Katie
NOW PLAYING
Eli Lilly’s Obesity Pill & Tim Cook at the White House 8/7/25
No transcript for this episode yet
Similar Episodes
Mar 14, 2026 ·23m
Mar 11, 2026 ·16m
Feb 28, 2026 ·14m